AUTOLUS THERAPEUTICS PLC — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/f0a3b62c-cfcd-45ed-822f-bfbca640da30/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $75.4M | 2025-01-01 – 2025-12-31 | evidence 0001730463-26-000038 |
| FY 2024 | $10.1M | 2024-01-01 – 2024-12-31 | evidence 0001730463-26-000038 |
| FY 2023 | $1.7M | 2023-01-01 – 2023-12-31 | evidence 0001730463-25-000019 |
| FY 2019 | $2.9M | 2019-01-01 – 2019-12-31 | evidence 0001628280-20-002797 |
| FY 2018 | $1.4M | 2017-10-01 – 2018-09-30 | evidence 0001730463-18-000005 |
| FY 2017 | $1.7M | 2016-10-01 – 2017-09-30 | evidence 0001730463-18-000005 |
| FY 2016 | $1.2M | 2015-10-01 – 2016-09-30 | evidence 0001730463-18-000005 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AUTOLUS THERAPEUTICS PLC — all facts · Net Income · Operating Income